Structured page family:Cost guide

Liraglutide Cost Guide: Insurance, Cash Pay, and Savings

In the United States, Liraglutide costs depend on brand, pharmacy, insurance design, and whether the patient qualifies for manufacturer savings programs.

Active Market
This page is designed for US treatment decisions and uses US-first pricing and savings sources.
Official pricing
Verify current pricing directly on official Victoza pages before starting, because list pricing, self-pay offers, and eligibility terms can change.
Cash-pay reality
Official cash-pay pricing varies by pharmacy and dose. Contact multiple pharmacies or use a prescription discount service for current rates.
Insurance coverage
Commercial coverage for Liraglutide varies by plan and indication. Prior authorization is commonly required.
Savings and coupons
Manufacturer savings programs may reduce out-of-pocket cost for eligible commercially insured patients.
Prior Authorization
Prior authorization is common and may require documentation of diagnosis, prior treatments, and clinical need.

Price Breakdown

List price (monthly)
~$1,349 (Saxenda 3.0 mg); ~$1,100 (Victoza 1.8 mg)
Average wholesale price
~$1,200-$1,300/month
Pharmacy acquisition estimate
~$1,050-$1,200/month
Typical negotiated rate
~$700-$950/month after rebates
Price per dose
~$45 per 3.0 mg (Saxenda); ~$37 per 1.8 mg (Victoza)
Annual cost at list price
~$16,200 (Saxenda); ~$13,200 (Victoza)

Pharmacy Price Comparison

PharmacyPrice RangeNotes
Retail chains (cash)$1,250-$1,400/monthStandard retail pricing
Costco$1,150-$1,300/monthModest discount
GoodRx$1,000-$1,250/monthVariable
Novo Nordisk direct$200-$500/monthWith savings card

Insurance Coverage Landscape

Commercial plans
~40-50% for Saxenda (obesity); ~80-90% for Victoza (T2D)
Medicare Part D
Victoza covered for T2D; Saxenda obesity coverage under IRA expansion
Medicaid
Victoza commonly covered for T2D; Saxenda varies by state
VA coverage
Victoza on formulary for T2D
TRICARE
Victoza covered for T2D; Saxenda limited
Employer plan typical tier
Tier 3; copay $40-100 or coinsurance 20-30%

Prior Authorization Guide

Required Documentation
  • BMI criteria for Saxenda; HbA1c for Victoza
  • Lifestyle intervention documentation
  • Step therapy failures
Common Denial Reasons
  • Obesity medication exclusion
  • Missing step therapy
  • BMI below threshold
Appeal Template Points
  • FDA-approved indication met
  • Documented comorbidities
  • Guideline-concordant therapy
Expected timeline: 3-5 days initial; 30 days appeal

Savings Programs and Patient Assistance

Saxenda Savings Card
copay
Eligibility: Commercially insured
Savings: $200-$500/month
Income limit: None
Enrollment: simple
Not for Medicare/Medicaid
Victoza Savings Card
copay
Eligibility: Commercially insured T2D
Savings: $25/month up to 24 months
Income limit: None
Enrollment: simple
Requires T2D diagnosis
Novo Nordisk PAP
manufacturer
Eligibility: Uninsured, ≤400% FPL
Savings: Free
Income limit: ≤400% FPL
Enrollment: moderate
Annual application

Generic and Biosimilar Status

No generic currently available
Expected: Patent expires late 2020s; generic entry may reduce cost significantly

Cost by Dose

Dose/RegimenMonthlyAnnual
Victoza 0.6-1.8 mg$1,100$13,200
Saxenda 3.0 mg$1,349$16,200

Annual Cost Projection

Year 1
$3,000-$16,200
Year 2
$3,000-$16,200
Year 3
$3,000-$16,200 (generic may emerge)
Assumptions
  • No generic yet
  • Insurance stable

Cost-Saving Strategies

  • 1.Use Victoza for T2D if obesity indication denied (better coverage)
  • 2.Saxenda savings card for commercially insured
  • 3.Novo Nordisk PAP for uninsured
  • 4.Prepare for generic availability in late 2020s

International Price Comparison

CountryPrice RangeNotes
UK~£150-200/month (~$190-250)NHS
Canada~CAD $300-400 (~$220-300)Regulated

Need help comparing liraglutide paths?

Use the provider matcher to package treatment interest, insurance, budget, urgency, and state context before you commit to a prescribing path.

Find a liraglutide provider
Trust Summary
Reviewed 2026-04-27 by PeptideScholar editorial review. This page currently cites 3 official sources.
Pricing, savings eligibility, and coverage rules can change quickly. Verify all current figures and terms directly on official brand pages before acting.

Liraglutide Cost FAQ

Sources

  1. 1. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med • 2016
    Claim type: clinical
    View source →
  2. 2. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
    N Engl J Med • 2015
    Claim type: clinical
    View source →
  3. 3. FDA Information on Liraglutide
    FDA • 2026
    Claim type: regulatory
    View source →

This content is for informational purposes only and does not constitute medical advice.